Abstract
Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
A E Mutlib, J Jurcak and N Hrib
Drug Metabolism and Disposition October 1996, 24 (10) 1139-1150;